Organisation paid for research Program year 2021 Source: CMS Open Payments

Anovorx Group LLC

Neither a doctor nor a teaching hospital

Research payments

$311,652

60 payments

Through program year 2021, Anovorx Group LLC is reported as receiving $311,652 in research payments, across 60 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$165,093	33
2020	Research	$128,817	19
2019	Research	$17,743	8

Breakdown

Who paid Research payments · program years 2019–2021

Genentech, Inc. $311,652 60 payments

Studies the money was for Research payments · program years 2019–2021

Ipatasertib in Combination With Paclitaxel in TNBC and HR Breast Cancer $66,615 12 payments
1L Mtnbc Ipatasertib Tecentriq Paclitaxel $66,137 7 payments
A Phase III Trial of GDC 9545 in Combination With Palbo in HR Her2 Neg 1L MBC $65,912 8 payments
Phase 3 Study of Anti Pdl1 With Abraxane in TN MBC $49,844 11 payments
Tumor Agnostic Precision Immuno Oncology and Somatic Targeting Rational for You Tapistry Phase II $28,670 7 payments
A Multicenter Low Interventional Study to Develop A Prospective Clinicogenomic Program $27,056 7 payments
A Phase III Trial in Adjuvant Her2 BC PTS $6,919 7 payments
R Benda Cd79b $500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.